Incyte (INCY) Cash & Equivalents (2010 - 2026)

Incyte has reported Cash & Equivalents for 17 years, with the latest figure at $3.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 78.25% year-over-year to $3.5 billion; the trailing twelve-month figure through Mar 2026 stood at $3.5 billion (up 78.25% YoY), and the FY2025 full-year result was $3.1 billion, up 83.54% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $3.5 billion, up from $3.1 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $3.5 billion in Q1 2026, with the low at $987.3 million in Q2 2024.
• Historically, Cash & Equivalents has averaged $2.5 billion across 5 years, with a median of $2.7 billion in 2022.
• Annual changes were most pronounced in 2024 — Cash & Equivalents slumped 68.47% — and 2025, when it surged 98.01%.
• Incyte's Cash & Equivalents stood at $3.0 billion in 2022, then grew by 8.88% to $3.2 billion in 2023, then sank by 47.47% to $1.7 billion in 2024, then jumped by 83.54% to $3.1 billion in 2025, then rose by 11.73% to $3.5 billion in 2026.
• The last three Cash & Equivalents figures came in at $3.5 billion (Q1 2026), $3.1 billion (Q4 2025), and $2.5 billion (Q3 2025), per Business Quant data.